TOKYO (Reuters) - Pfizer Inc. (PFE.N: Quote, Profile , Research), the world's largest drug maker, plans to reduce staff by up to 20 percent at its pharmaceuticals division in Japan, but the head of the Japanese unit said he could not say if a research center would be closed as planned.
